Chronic GVHD of the skin happens when the donor’s cells attack your skin. It is the most common type of chronic GVHD. Chronic GVHD of the skin can cause color changes (red, pink, purple, brown or white), thinning or thickening, hardening, rashes, scaly areas, bumps, sores or blisters (small pockets of fluid).

Does skin GVHD go away?

GVHD usually goes away a year or so after the transplant, when your body starts to make its own white blood cells from the donor cells. But some people have to manage it for many years.

How is graft vs host disease diagnosed?

The diagnosis of acute GVHD can be made readily on clinical grounds in the patient who presents with a classic maculopapular rash, abdominal cramps with diarrhea, and a rising serum bilirubin concentration within two to three weeks following hematopoietic cell transplantation (HCT).

What is GVHD skin?

Chronic graft-versus-host disease (GVHD) of the skin is common following a transplant using cells from a donor (allogeneic transplant). It can affect different layers of the skin as well as the mouth, genitals, hair and sweat glands.

Can graft vs host be cured?

Chronic GVHD is treatable — usually, patients are treated first with corticosteroids, but those also come with their own set of side effects.

What is life expectancy after bone marrow transplant?

Although only 62% of patients survived the first year post-BMT, 98.5% of patients alive after 6 years survived at least another year. Almost 1/3 (31%) of the deaths in long-term survivors resulted from causes unrelated to transplantation or relapse.

Is graft vs host disease an autoimmune disease?

Many of the clinical, histological and serological manifestations of chronic graft-versus-host disease (GVHD) resemble autoimmune disease (AD), and although the differences are significant, they may be more semantic than biological.

What are the signs and symptoms of graft-versus-host disease?

Sometimes tingling or burning or pain lancing across the skin. Again, these are because the nerves are effected. As chronic graft-versus-host disease progresses sometimes the skin will get very thin, and usually because patients are also taking steroids, [they are] already also contributing to thin skin and sometimes tearing of the skin.

Can peripheral blood stem cell source prevent graft-versus-host disease?

Use of peripheral blood stem cell source versus a bone marrow source has been actually studied in a clinical trial and has been shown to be a risk factor for graft-versus-host disease, but again we’re coming up with better regimens for prevention of graft-versus-host disease so hopefully we can overcome this risk factor.